Prima Sanjiwani Saraswati Sudarsa, Mario Korwa, and Nyoman Suryawati, “Therapeutic Outcomes of Secukinumab 300 mg in Severe Psoriasis Vulgaris with Metabolic Comorbidities: A Retrospective Cohort Study in Bali”, Bioscmed, vol. 10, no. 4, pp. 1048-1096, Jan. 2026.